CCIA
DPLO

Campbell & Co Investment Adviser’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Campbell & Co Investment Adviser’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-9,181
Closed -$235K – 580
2018
Q2 		$235K Buy
+9,181
New +$214K 0.18% 265

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Campbell & Co Investment Adviser's DPLO Position: Q3 2018 in Review

Campbell & Co Investment Adviser sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q3 2018, closing a stake of 9,181 shares — an estimated $235K sold.

Campbell & Co Investment Adviser first reported a position in DPLO in Q2 2018 and held it in 1 quarter. The position peaked at $235K in Q2 2018. 178 funds tracked by Wall St. Rank hold DPLO as of Q3 2018.

  • Campbell & Co Investment Adviser reported no remaining DIPLOMAT PHARMACY, INC. position as of Q3 2018 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 9,181 DIPLOMAT PHARMACY, INC. shares in Q3 2018, an estimated $235K.
  • Campbell & Co Investment Adviser first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2018 and held it in 1 quarter.
  • Campbell & Co Investment Adviser's DIPLOMAT PHARMACY, INC. position peaked at $235K in Q2 2018.
  • 178 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q3 2018.

Based on Campbell & Co Investment Adviser's 13F filing for Q3 2018, filed 8 Nov 2018.